US Stock MarketDetailed Quotes

MBX MBX Biosciences

Watchlist
  • 11.280
  • +0.790+7.53%
Close May 1 16:00 ET
  • 10.640
  • -0.640-5.67%
Pre 08:00 ET
377.03MMarket Cap-6.09P/E (TTM)

About MBX Biosciences Company

MBX Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of peptide therapies for the treatment of endocrine and metabolic disorders. Its product candidates and programs include MBX 2109, MBX 1416, and obesity portfolio. The company was founded by Peter Kent Hawryluk and Richard D. DiMarchi in August 2018 and is headquartered in Carmel, IN.

Company Profile

SymbolMBX
Company NameMBX Biosciences
Listing DateSep 13, 2024
Issue Price16.00
Founded2018
CEOMr. Peter Kent Hawryluk
MarketNASDAQ
Employees43
Fiscal Year Ends12-31
Address11711 North Meridian Street,Suite 300
CityCarmel
ProvinceIndiana
CountryUnited States of America
Zip Code46032
Phone1-317-659-0200
Websitehttp://www.mbxbio.com

Company Executives

  • Name
  • Position
  • Salary
  • Peter Kent Hawryluk
  • President, Chief Executive Officer and Director
  • 2.24M
  • Richard B. Bartram
  • Chief Financial Officer and Principal Accounting Officer
  • 1.15M
  • Dr. Salomon Azoulay, M.D.
  • Chief Medical Officer
  • 3.10M
  • Stephen L. Hoerter
  • Independent Director
  • --
  • Steven L. Hoerter
  • Independent Director
  • --
  • Patrick J. Heron
  • Lead Independent Director
  • 213.31K
  • James M. Cornelius
  • Independent Director
  • 366.73K
  • Edward T. Mathers
  • Independent Director
  • 205.75K
  • Dr. Tiba Aynechi, PhD
  • Independent Director
  • 207.06K
  • Dr. Steven Ryder, M.D.
  • Independent Director
  • 478.96K
  • Dr. Ora H. Pescovitz, M.D.
  • Independent Director
  • 422.26K
  • Dr. Carl L. Gordon, C.F.A.,PhD
  • Independent Director
  • 206.77K

Market Insights

Inverse ETF Inverse ETF
No. Symbol Turnover
Sample Name
Sample Code
 4.00B
Sample Name
Sample Code
 1.06B
Sample Name
Sample Code
 533.62M
4
ProShares UltraPro Short S&P500 ETF
SPXU
420.96M
5
Tradr 2X Short TSLA Daily ETF
TSLQ
404.67M
Unlock Now

Discussing

Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks Show More
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 425.400
Sample Name
Sample Code
 14.050
Sample Name
Sample Code
 572.210
4
Oracle
ORCL
145.490
5
Amazon
AMZN
190.200
Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 425.400
Sample Name
Sample Code
 572.210
Sample Name
Sample Code
 172.720
4
Oracle
ORCL
145.490
5
Amazon
AMZN
190.200
Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Sample Name
Sample Code
 3.240
Sample Name
Sample Code
 0.1731
Sample Name
Sample Code
 10.440
4
Abits
ABTS
2.860
5
Hut 8
HUT
13.510
Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

- No more -